We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The Vectra multi-biomarker disease score, ...
SALT LAKE CITY, Nov. 09, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in precision medicine, announced that its Myriad Autoimmune business unit will present new data ...
Please provide your email address to receive an email when new articles are posted on . The American College of Rheumatology has added the Vectra blood test, developed by Myriad Genetics, to its list ...
SALT LAKE CITY, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced new data from two studies of Vectra ® that evaluated ...
Myriad Genetics, Inc.MYGN recently came up with a favorable study result on the company's adjusted Vectra score. Published in the journal Rheumatology, this study announced results from a large ...
SALT LAKE CITY, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics and precision medicine, announced that the American College of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results